MX346884B - Nuevos portadores recubiertos de agente activo de liberacion controlada. - Google Patents
Nuevos portadores recubiertos de agente activo de liberacion controlada.Info
- Publication number
- MX346884B MX346884B MX2014005466A MX2014005466A MX346884B MX 346884 B MX346884 B MX 346884B MX 2014005466 A MX2014005466 A MX 2014005466A MX 2014005466 A MX2014005466 A MX 2014005466A MX 346884 B MX346884 B MX 346884B
- Authority
- MX
- Mexico
- Prior art keywords
- active agent
- calcium carbonate
- controlled release
- natural
- release active
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title abstract 4
- 239000000969 carrier Substances 0.000 title abstract 3
- 238000013270 controlled release Methods 0.000 title abstract 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 8
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract 4
- 229910000019 calcium carbonate Inorganic materials 0.000 abstract 4
- 229910002092 carbon dioxide Inorganic materials 0.000 abstract 2
- 239000001569 carbon dioxide Substances 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 238000010306 acid treatment Methods 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 239000007795 chemical reaction product Substances 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 238000011065 in-situ storage Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
- A01N25/28—Microcapsules or nanocapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Toxicology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Abstract
La presente invención se refiere a portadores para la liberación controlada de agentes activos, que comprenden un núcleo, contienen carbonato de calcio natural o sintético que ha reaccionado superficialmente y por lo menos un agente activo, en donde el por lo menos un agente activo está asociado con el carbonato de calcio natural o sintético que ha reaccionado superficialmente, y en donde el carbonato de calcio natural o sintético que ha reaccionado superficialmente es un producto de la reacción de carbonato de calcio natural o sintético con dióxido de carbono y uno o más ácidos, en donde el dióxido de carbono es formado in situ mediante el tratamiento con ácido y/o es suministrado desde una fuente externa, y un recubrimiento que encapsula el núcleo. Se refiere además a la preparación de portadores cargados, así como también a su uso en diferentes aplicaciones.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11188597.6A EP2591772B1 (en) | 2011-11-10 | 2011-11-10 | New coated controlled release active agent carriers |
| US201161559253P | 2011-11-14 | 2011-11-14 | |
| PCT/EP2012/072161 WO2013068478A1 (en) | 2011-11-10 | 2012-11-08 | New coated controlled release active agent carriers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014005466A MX2014005466A (es) | 2014-08-22 |
| MX346884B true MX346884B (es) | 2017-04-05 |
Family
ID=47143128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014005466A MX346884B (es) | 2011-11-10 | 2012-11-08 | Nuevos portadores recubiertos de agente activo de liberacion controlada. |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US9579291B2 (es) |
| EP (1) | EP2747752B1 (es) |
| KR (1) | KR101612655B1 (es) |
| CN (1) | CN103957893B (es) |
| AU (1) | AU2012334082B2 (es) |
| BR (1) | BR112014011310B1 (es) |
| CA (1) | CA2851069C (es) |
| CL (1) | CL2014001172A1 (es) |
| CO (1) | CO6940430A2 (es) |
| DK (1) | DK2747752T3 (es) |
| ES (1) | ES2553091T3 (es) |
| IL (1) | IL231959A0 (es) |
| IN (1) | IN2014MN00843A (es) |
| MX (1) | MX346884B (es) |
| MY (1) | MY168425A (es) |
| PH (1) | PH12014500750A1 (es) |
| PL (1) | PL2747752T3 (es) |
| PT (1) | PT2747752E (es) |
| RU (2) | RU2018123688A (es) |
| SG (1) | SG11201401350WA (es) |
| SI (1) | SI2747752T1 (es) |
| SM (1) | SMT201600010B (es) |
| TW (1) | TWI625129B (es) |
| WO (1) | WO2013068478A1 (es) |
| ZA (1) | ZA201403611B (es) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2719376T3 (en) | 2012-10-12 | 2015-06-15 | Omya Int Ag | Gastroretentiv drug formulation and delivery systems and their method of preparation by the use of functional calcium carbonate |
| JP2016514095A (ja) * | 2013-02-15 | 2016-05-19 | ウェルマーク インターナショナルＷｅｌｌｍａｒｋ Ｉｎｔｅｒｎａｔｉｏｎａｌ | 無機飼料を介する製剤 |
| ES2690413T3 (es) | 2015-06-10 | 2018-11-20 | Omya International Ag | Uso de carbonato cálcico tratado mediante reacción superficial como agente antibloqueo |
| EP3176222A1 (en) * | 2015-12-01 | 2017-06-07 | Omya International AG | Method for the production of granules comprising surface-reacted calcium carbonate |
| WO2017155906A1 (en) | 2016-03-08 | 2017-09-14 | Living Proof, Inc. | Long lasting cosmetic compositions |
| EP3275947A1 (en) * | 2016-07-25 | 2018-01-31 | Omya International AG | Surface-reacted calcium carbonate with functional cations |
| EP3400810A1 (en) * | 2017-05-11 | 2018-11-14 | Omya International AG | Surface-reacted calcium carbonate in food |
| CN107258776A (zh) * | 2017-06-29 | 2017-10-20 | 山东大农药业有限公司 | 一种缓释农药颗粒剂及其制备方法 |
| US10987300B2 (en) | 2017-09-13 | 2021-04-27 | Living Proof, Inc. | Long lasting cosmetic compositions |
| US10842729B2 (en) | 2017-09-13 | 2020-11-24 | Living Proof, Inc. | Color protectant compositions |
| US11510877B2 (en) | 2017-10-10 | 2022-11-29 | Capsugel Belgium Nv | Gelling multiparticulates |
| CN111356501A (zh) | 2017-11-20 | 2020-06-30 | 生活实验公司 | 实现持久化妆品性能的属性 |
| EP3520798A1 (en) * | 2018-01-31 | 2019-08-07 | Omya International AG | Use of functionalized calcium carbonate as active ingredient |
| AU2019257739B2 (en) | 2018-04-27 | 2025-01-09 | Living Proof, Inc. | Long lasting cosmetic compositions |
| EP3598105A1 (en) | 2018-07-20 | 2020-01-22 | Omya International AG | Method for detecting phosphate and/or sulphate salts on the surface of a substrate or within a substrate, use of a lwir detecting device and a lwir imaging system |
| KR102739456B1 (ko) * | 2018-10-31 | 2024-12-09 | (주)아모레퍼시픽 | 바이오 폴리머를 포함하는 코어-쉘 네트워크 구조체 및 이를 포함하는 조성물 |
| WO2020091456A1 (ko) * | 2018-10-31 | 2020-05-07 | ㈜아모레퍼시픽 | 바이오 폴리머를 포함하는 코어-쉘 네트워크 구조체 및 이를 포함하는 조성물 |
| WO2020149481A1 (ko) * | 2019-01-16 | 2020-07-23 | 영남대학교 산학협력단 | 알지네이트 겔을 이용한 미세캡슐 조성물 및 이의 제조방법 |
| KR20210069344A (ko) | 2019-12-03 | 2021-06-11 | (주)아모레퍼시픽 | 바이오 폴리머를 포함하는 효능물질 전달체 |
| CN111436426B (zh) * | 2020-05-11 | 2022-04-08 | 北京首创股份有限公司 | 供水管道输水用二次加氯胶囊及其制备方法 |
| AR123009A1 (es) | 2020-07-20 | 2022-10-19 | Omya Int Ag | Agente estabilizante para composición probiótica |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2223896A1 (de) | 1972-05-17 | 1973-11-29 | Sanol Arznei Schwarz Gmbh | Verfahren zum ueberziehen von feinteiligen arzneimitteln |
| US4657784A (en) | 1986-03-10 | 1987-04-14 | Ecolab Inc. | Process for encapsulating particles with at least two coating layers having different melting points |
| ATE180668T1 (de) * | 1992-12-01 | 1999-06-15 | Spirig Ag | S(+)-ibuprofen enthaltende arzneimittel |
| US5958458A (en) * | 1994-06-15 | 1999-09-28 | Dumex-Alpharma A/S | Pharmaceutical multiple unit particulate formulation in the form of coated cores |
| FR2787802B1 (fr) | 1998-12-24 | 2001-02-02 | Pluss Stauffer Ag | Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications |
| FR2852600B1 (fr) | 2003-03-18 | 2005-06-10 | Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages | |
| FR2871474B1 (fr) | 2004-06-11 | 2006-09-15 | Omya Development Ag | Nouveau pigment mineral sec contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages |
| EP1891937A1 (en) | 2006-08-25 | 2008-02-27 | Novartis AG | Galenic formulations of aliskiren |
| ES2342495T3 (es) * | 2007-03-21 | 2010-07-07 | Omya Development Ag | Procedimiento de eliminacion de compuestos disruptores endocrinos. |
| PT2070991E (pt) | 2007-12-12 | 2010-10-25 | Omya Development Ag | Processo para produção de carbonato de cálcio precipitado reagido em superfície |
| EP2168572A1 (en) * | 2008-09-30 | 2010-03-31 | Omya Development Ag | New controlled release active agent carrier |
| WO2010121619A1 (en) | 2009-04-24 | 2010-10-28 | Fertin Pharma A/S | Chewing gum and particulate material for controlled release of active ingredients |
| RS52296B (en) | 2009-06-15 | 2012-12-31 | Omya Development Ag | PROCEDURE FOR OBTAINING SURFACES OF CALCIUM CARBONATE AND ITS USE |
| EP2264108B1 (en) | 2009-06-15 | 2012-02-15 | Omya Development AG | Process to prepare a surface-reacted calcium carbonate implementing a weak acid |
-
2012
- 2012-10-29 TW TW101139890A patent/TWI625129B/zh not_active IP Right Cessation
- 2012-11-08 PH PH1/2014/500750A patent/PH12014500750A1/en unknown
- 2012-11-08 SG SG11201401350WA patent/SG11201401350WA/en unknown
- 2012-11-08 IN IN843MUN2014 patent/IN2014MN00843A/en unknown
- 2012-11-08 KR KR1020147015774A patent/KR101612655B1/ko active IP Right Grant
- 2012-11-08 PL PL12781346T patent/PL2747752T3/pl unknown
- 2012-11-08 US US14/349,850 patent/US9579291B2/en active Active
- 2012-11-08 PT PT127813467T patent/PT2747752E/pt unknown
- 2012-11-08 AU AU2012334082A patent/AU2012334082B2/en active Active
- 2012-11-08 BR BR112014011310-6A patent/BR112014011310B1/pt active IP Right Grant
- 2012-11-08 DK DK12781346.7T patent/DK2747752T3/en active
- 2012-11-08 SI SI201230345T patent/SI2747752T1/sl unknown
- 2012-11-08 WO PCT/EP2012/072161 patent/WO2013068478A1/en active Application Filing
- 2012-11-08 ES ES12781346.7T patent/ES2553091T3/es active Active
- 2012-11-08 RU RU2018123688A patent/RU2018123688A/ru unknown
- 2012-11-08 RU RU2014123532A patent/RU2665382C1/ru active
- 2012-11-08 MX MX2014005466A patent/MX346884B/es active IP Right Grant
- 2012-11-08 MY MYPI2014701204A patent/MY168425A/en unknown
- 2012-11-08 CA CA2851069A patent/CA2851069C/en not_active Expired - Fee Related
- 2012-11-08 CN CN201280055056.6A patent/CN103957893B/zh active Active
- 2012-11-08 EP EP12781346.7A patent/EP2747752B1/en active Active
-
2014
- 2014-04-06 IL IL231959A patent/IL231959A0/en unknown
- 2014-04-30 CO CO14093176A patent/CO6940430A2/es unknown
- 2014-05-06 CL CL2014001172A patent/CL2014001172A1/es unknown
- 2014-05-19 ZA ZA2014/03611A patent/ZA201403611B/en unknown
-
2016
- 2016-01-11 SM SM201600010T patent/SMT201600010B/it unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12014500750A1 (en) | New coated controlled release active agent carriers | |
| TN2014000141A1 (en) | New coated controlled release active agent carriers | |
| UY32151A (es) | Nuevo portador de agentes activos liberados de forma controlada | |
| PH12013501143A1 (en) | Substituted 1-benzylcycloalkylcarboxlic acids and use thereof | |
| NZ705985A (en) | Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same | |
| MY183859A (en) | Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate | |
| MX356097B (es) | Proceso para la preparacion de nanoparticulas terapeuticas. | |
| TN2011000370A1 (en) | Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof | |
| EA033455B1 (ru) | Кристаллические формы замещенных 5-фтор-1h-пиразолопиридинов, способы их получения, их применение для получения лекарственного средства, лекарственное средство и способ лечения на их основе | |
| MX340125B (es) | 2-hidroxi-4-(metiltio) butironitrilo estable en almacenamiento. | |
| IN2014CN03118A (es) | ||
| SG191068A1 (en) | New form of administration of enkephalinase inhibitor | |
| IN2014DN08496A (es) | ||
| MX2012002507A (es) | Sales de percarbonato expandido, metodos de produccion y usos de la mismas. | |
| RS51838B (en) | COALS AND SULFURIC ACIDS Salts 3- (2,2,2-trimethylhydrazinium) ester propionate and their uses for the preparation of 3- (2,2,2-trimethylhydrazinium) dihydrate propionate | |
| MY171509A (en) | Toothpaste composition | |
| SI2687506T1 (sl) | Postopek za encimsko sintezo (7S)-1-(3,4-dimetoksibiciklo(4.2.0)okta-1,3,5-trien-7-il) N-metil metanamina ter uporaba za sintezo ivabradina in njegovih soli | |
| IN2014MN00358A (es) | ||
| EP2589621A4 (en) | PROCESS FOR DECOMPOSING POLYMYLIC ACID | |
| WO2014049020A3 (de) | Vorrichtung und verfahren zur beschichtung von substraten | |
| UA61374U (ru) | Способ стабилизаци полугидрата сульфата кальция | |
| TH152833A (th) | ตัวนำส่งสารออกฤทธิ์ที่ปลดปล่อยอย่างควบคุมชนิดเคลือบแบบใหม่ | |
| TN2013000243A1 (en) | Substituted 1-benzylcycloalkylcarboxlic acids and use thereof | |
| EP2528861A4 (en) | ACTIVE OXYGEN SOURCE | |
| UA72733U (ru) | Амиды 5-феноксиметил-1,3,4-оксадиазол-2-ил-тиоацетатной кислоты, которые проявляют противосудорожную активность |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |